The submission deadline was Tuesday, June 1, 2021. However, we are accepting late breaking abstracts! We welcome your submissions until July 5.

About the Conference

This inaugural conference, Stem Cell and Gene Therapy for Neurodevelopmental Disorders, is an early discussion of the development of safe and effective treatments for children suffering from genetic diseases. New advances in this field are actively studied by the expert speakers for this conference, who are all working on cutting-edge research that has the goal of providing future treatments.

 The conference is strongly focused on evidence-based science. In bringing these novel cell and gene therapy trials from bench to bedside and into clinical practice, many scientists, physicians, healthcare, regulatory, manufacturing and other staff members must work together in large teams. Our goal is to enhance collaborative research in the fields of Cell and Gene Therapy for Neurodevelopmental Disabilities.

Conference Information

Targeted Audience: Scientists, Researchers, Clinical Researchers, Post-doctoral Scholars, and Graduate Students
Limited abstract awards (denominations of $250-$500) are available for postdoctoral scholars and graduate students.

When: September 24-25, 2021

Location: Virtual and UC Davis MIND Institute